Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer von Kraya, Adam A, Maxwell, Kara N, Wubbenhorst, Bradley, Wenz, Brandon M, Pluta, John, Rech, Andrew J, Dorfman, Liza M, Lunceford, Nicole, Barrett, Amanda, Mitra, Nandita, Morrissette, Jennifer J D, Feldman, Michael, Nayak, Anupma, Domchek, Susan M, Vonderheide, Robert H, Nathanson, Katherine L

Volltext

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma von Huang, Alexander C., Orlowski, Robert J., Xu, Xiaowei, Mick, Rosemarie, George, Sangeeth M., Yan, Patrick K., Manne, Sasikanth, Kraya, Adam A., Wubbenhorst, Bradley, Dorfman, Liza, D’Andrea, Kurt, Wenz, Brandon M., Liu, Shujing, Chilukuri, Lakshmi, Kozlov, Andrew, Carberry, Mary, Giles, Lydia, Kier, Melanie W., Quagliarello, Felix, McGettigan, Suzanne, Kreider, Kristin, Annamalai, Lakshmanan, Zhao, Qing, Mogg, Robin, Xu, Wei, Blumenschein, Wendy M., Yearley, Jennifer H., Linette, Gerald P., Amaravadi, Ravi K., Schuchter, Lynn M., Herati, Ramin S., Bengsch, Bertram, Nathanson, Katherine L., Farwell, Michael D., Karakousis, Giorgos C., Wherry, E. John, Mitchell, Tara C.

Volltext

Abstract 1682: Non-V600 BRAF mutants in melanoma: Multiple MAPK mutations and distinctive RNA expression von Kiernan, Elizabeth, Bastian, Paul, Dorfman, Liza, Anastopoulos, Ioannis N., Wubbenhorst, Brad, Krepler, Clemens, Rebecca, Vito, Herlyn, Meenhard, Nathanson, Katherine

Volltext